top button
    Got Questions


Global IoT Summit 2018
Oct 31, 2018
The Leela Palace, Bangalore



    Connect to us
      Facebook Login
      Site Registration Why to Join

Facebook Login
Site Registration

Patient Handling Equipment Market Segments, Leading Player, Application & Forecast Analysis

0 votes
7 views

The global patient handling equipment market has been anticipated in a report by Transparency Market Research (TMR) to bear a highly competitive landscape for the next few years. The analysts authoring the report profile some of the leading players of the market such as Etac AB, Hill-Rom Holdings, Inc., V. Guldmann A/S, DJO Global, and ArjoHuntleigh. Important players of the market have been predicted to focus on a variety of strategies including technological development, acquisition, new product launch, and tactical collaboration. One of the finest instances to follow could be the new specialist pediatric bed launched by Sidhil Ltd. in 2016. The launch had been made with the expectation of further improving the company’s sales and as an extension to its current offerings.

TMR has prognosticated the global patient handling equipment market to rise at a 10.4% CAGR during the completion of the forecast tenure 2017-2024. By the end of 2024, the market could touch revenue earnings worth a US$22.4 bn. In terms of product-wise segmentation, it has been foreseen to witness the dominance of medical beds that took a colossal share in the recent past. By region, Europe had stayed at the top of the market in the recent years. However, even until the end of the forecast period, the region has been projected to take the lead in the market.

Planning To Lay Down Future Strategy? Request Brochure Of Patient Handling Equipment Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6577

Rental Provisions Emerging as Market Trend to Create New Prospects

Rental provisions for patients requiring temporary lifts and slings have been envisaged to be one of the primary reasons for the rise in the demand for patient handling equipment in healthcare centers. The need to avoid the risk of developing musculoskeletal injuries to both patients and caregivers when manually lifting patients could be another factor augmenting the demand in the world patient handling equipment market.

Healthcare centers in developed nations could incentivize the adoption of patient handling equipment because of the high benefit to investment cost ratio. Patient handling equipment minimize the role of caregivers in patient assistance. Additionally, labor expenses could be directed to the purchase of patient handling equipment such as medical beds with assistive technology and patient lifts.

To Obtain All-Inclusive Information On Forecast Analysis Of Patient Handling Equipment Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=6577

Worries about Return on Investment in Expensive Equipment Limit Adoption

With end users nervous about returns on investment in exorbitant technologically advanced equipment and low awareness among the general public, the international patient handling equipment market could see a fall in growth during the course of the forecast period. Furthermore, lack of regulatory and legal protocols for patient handling in emerging nations such as Sri Lanka and India has been foretold to hinder market growth in the coming years.

Nevertheless, there could be a rollout of new policies in favor of a healthcare system that is patient-centered because of rising pressure from international authorities. Moreover, high focus on implementing a decent work culture and improving patient care quality have been forecast to create promising opportunities in the international patient handling equipment market.

posted Feb 11 by Rohini Chaudhari

  Promote This Article
Facebook Share Button Twitter Share Button Google+ Share Button LinkedIn Share Button Multiple Social Share Button

Related Articles
0 votes

Benzodiazepine anticonvulsant drugs are effective in preventing or controlling seizures or convulsions. Various types of gamma-amino-butyric acid-A (GABA-A) receptor subtypes are enhanced by the action of benzodiazepines. Different subtypes of benzodiazepines have different effects due to difference in their affinity. According to a research study, α-1-GABA-A, one of the GABA-A subtypes, is responsible for moderating sedation, amnesia, and anticonvulsant activity. α-2-GABA-A, another subtype, moderates anxiety. Benzodiazepine anticonvulsant drugs have high affinity for α-1-GABA-A. Examples of benzodiazepine anticonvulsant drugs are midazolam, lorazepam, diazepam, clorazepate, clonazepam, and clobazam.

Report overview @ https://www.transparencymarketresearch.com/benzodiazepine-anticonvulsant-drugs-market.html

Seizures are also known as convulsions. The patient experiences jerking of legs, arms, or face. Various types of seizures could happen to people of any age, lasting for few minutes or seconds. Minor seizures can also be extremely dangerous if these occur while driving or swimming. Seizures that affect only one part of the brain are known as simple partial seizures or simple focal seizures. During a seizure, there may be loss of awareness, loss of memory, or mental confusion. Such seizures are known as focal dyscognitive seizures.

Rise in prevalence of seizures across the world drives the global benzodiazepine anticonvulsants drugs market. According to Healthline Media and Epilepsy Foundation of America, every year, nearly 150,000 people in the U.S. are diagnosed with CNS disorder which causes seizures. Healthline Media also stated that one in 26 people will be diagnosed with seizures in their lifetimes. Epilepsy is defined as having two or more unprovoked seizures.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=45177

According to the WHO, up to 10% of people across the world have one seizure during their lifetimes. The WHO also stated that nearly 50 million people are living with epilepsy across the globe presently. Every year, between 30 and 50 per 100,000 people are diagnosed with new cases of epilepsy in high-income countries, and this number is two times higher among low and middle income countries. Ketogenic diet is anticipated to restrain the global benzodiazepine anticonvulsants drugs market. A study conducted by the National Center for Biotechnology Information, U.S. National Library of Medicine revealed that ketogenic diet reduced the chances of seizures in children.

The global benzodiazepine anticonvulsant drugs market can be segmented based on indication, distribution channel, and region. In terms of indication, the market can be bifurcated into generalized seizures and focal (partial) seizures. Generalized seizures can be classified into tonic-clonic seizures, atonic seizures, myoclonic seizures, clonic seizures, and tonic seizures. Focal seizures can be categorized into dyscognitive focal seizures and simple focal seizures. Based on distribution channel, the global benzodiazepine anticonvulsant drugs market can be divided into retail pharmacies, online pharmacies, and hospital pharmacies.   

Geographically, the global benzodiazepine anticonvulsant drugs market can be segmented into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America held the largest market share in 2017, due to new drug launches and increased research and development on benzodiazepine anticonvulsants drugs. Europe held the second largest market share in 2017, owing to increased promotional activities to create awareness regarding the benefits associated with the use of benzodiazepine anticonvulsant drugs in the region.

Pre Book Benzodiazepine Anticonvulsant Drugs Market Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=45177&ltype=S

The market in Asia Pacific is anticipated to expand at the fastest growth rate during the forecast period owing to increase in government activities to increase awareness about benzodiazepine anticonvulsants drugs especially in countries such as China and India. Japan held significant market share in Asia Pacific in 2017 owing to high geriatric population in the country. The market in Middle East & Africa and Latin America is anticipated to grow at a moderate pace during the forecast period owing to rise in government initiatives regarding benzodiazepine anticonvulsants drugs in the regions.

Key players in the global benzodiazepine anticonvulsant drugs market include F. Hoffmann-La Roche Ltd., MEDA Manufacturing GmbH, Valeant Pharmaceuticals International, Inc., and H. Lundbeck A/S.

More Trending Reports by Transparency Market Research –

Hearing Aids Market: prnewswire.com/news-releases/hearing-aids-market-increasing-prevalence-of-hearing-loss-worldwide-augments-product-demand-says-tmr-300857268.html

Diabetes Drugs Market: prnewswire.com/news-releases/diabetes-drugs-market-value-to-reach-us584-billion-by-the-end-of-2025-transparency-market-research-663610203.html

0 votes

Roadside Drug Testing Devices Market: Introduction

Transparency Market Research has published a new report titled, ‘Global Roadside Drug Testing Devices Market’. According to the report, the global roadside drug testing devices market was valued at US$ 652 Mn in 2018 and is projected to expand at a CAGR of ~4% from 2019 to 2027.

Stringent Law Enforcement to Drive Adoption of Advanced Roadside Drug Testing Devices

Drug-impaired driving has emerged as a major public health issue. Alcohol and psychoactive drugs affect an individual’s ability to drive a motor vehicle safely. Increase in number of drug and alcohol abusers across the world presents significant opportunities for the test providers and manufacturers of drug abuse test products. According to the National Institute of Drug Abuse, alcohol, tobacco, and illicit drugs create an economic burden of nearly US$ 740 Bn in the U.S. in terms of related costs, lost work productivity, and healthcare. Technological advancements related to sample collection and efforts of manufacturers to create easy-to-use disposable test kits are expected to increase the demand for drug abuse testing products. Manufacturers focus on using samples other than urine such as sweat and hair, which are less embarrassing for individuals tested for drug abuse. Manufacturers also focus on development of rapid tests that provide faster results, are easy to use, and affordable compared to the tests conducted in laboratories.

Planning To Lay Down Future Strategy? Request Brochure Of Roadside Drug Testing Devices Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76205

Devices for Testing Alcohol Abuse to Witness High Demand

In terms of substance, the alcohol segment held major share of the global roadside drug testing devices market in 2018. The segment is projected to dominate the global market during the forecast period. The alcohol segment is anticipated to expand at a CAGR of ~4% from 2019 to 2027. Rise in consumption of alcohol and increase in incidence of driving under the influence of alcohol accelerate the growth of the global roadside drug testing devices market. Moreover, increase in approvals of roadside drug testing devices and rise in the impact of alcohol abuse on public health contribute to the growth of the global market.

Breath Analyzers to Lead Global Market

Based on sample type, the others segment, which includes breath, hair, and blood, accounted for significant share of the global roadside drug testing devices market in 2018. The segment is expected to expand at a moderate CAGR during the forecast period. Breath is the most common sample used for the detection of alcohol. Alcohol is the most widely used substance of abuse among drivers. According to data provided by the European DRUID project, alcohol is used by 3.48% drivers, illicit drugs by 1.90%, medicinal drugs by 1.36%, drug-drug combination by 0.39%, and alcohol-drug combination by 0.37%. The saliva segment is likely to witness strong growth during the forecast period. Roadside oral fluid or saliva testing is primarily being used in several countries to detect the presence of drugs. Countries such as Germany, Belgium, France, and Australia use saliva testing for identification of individuals driving under the influence of drugs (DUID).

To Obtain All-Inclusive Information On Forecast Analysis Of Roadside Drug Testing Devices Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=76205

Roadside Drug Testing Devices Market: Prominent Regions

North America held major share of the global roadside drug testing devices market in 2018. The market in the region is driven by presence of key players, high prevalence of driving under the influence of alcohol & illicit drugs, and growth strategies adopted by market players, including product approvals and launch, mergers, and acquisitions. According to Centers for Disease Control and Prevention (CDC) estimates, around 20.5 million people in the U.S. were reported driving under the influence of alcohol in 2018. Europe held the second largest share of the global roadside drug testing devices market in 2018.

Growth of the roadside drug testing devices market in the region can be attributed to rise in cases of driving under the influence of alcohol and increase in government initiatives to control road accidents & fatalities in various countries in Europe. Asia Pacific accounted for significant share of the global roadside drug testing devices market in 2018. The market in the region is projected to grow at a rapid pace during the forecast period. According to various studies, alcohol consumption is rising across Asia Pacific. Heavy episodic (binge) alcohol use has increased significantly in China, Thailand, Timor-Leste, and Vietnam. Rise in use of alcohol and other illicit drugs in the region is anticipated to drive the market in Asia Pacific during the forecast period. Moreover, implementation of strict driving laws in different countries in Asia Pacific can be attributed to the growth of the market in the region.

Roadside Drug Testing Devices Market: Key Players

Key players focus on strengthening their positions in the global roadside drug testing devices market. Rise in road fatalities due to drug-impaired driving has led to adoption of strict laws and regulations in several countries. This presents lucrative opportunities to key players to increase their share in the roadside drug testing devices market. Manufacturers are adopting strategies such as acquisitions, collaborations, and distribution to increase share in the global roadside drug testing devices market. In August 2019, Abbott and Intoximeters signed an agreement according to which, Intoximeters will market Abbott's SoToxa Mobile Test System (a handheld oral fluid roadside testing solution that rapidly and reliably detects recent drug use) along with its Alco-Sensor brand breath alcohol-testing products. This agreement will aid law enforcement agencies in their efforts to reduce the rate of drug driving, which has become a serious road safety issue.

Prominent players operating in the global roadside drug testing devices market are Drägerwerk AG & Co. KgaA, Abbott Laboratories, Oranoxis, Inc., CareHealth America, MAVAND Solutions GmbH, Pacific Data Systems Pty Ltd., Securetec, and UriTox, LLC.

More Trending Reports by Transparency Market Research –

In-vitro Colorectal Cancer Screening Tests Market - 

https://www.globenewswire.com/news-release/2019/02/21/1739306/0/en/In-vitro-Colorectal-Cancer-Screening-Tests-Market-to-Hit-US-980-6-Mn-by-2026-Owing-to-High-Diagnostic-Accuracy-TMR.html 

Sinus Dilation Devices Market  -

https://www.globenewswire.com/news-release/2019/02/22/1740326/0/en/Sinus-Dilation-Devices-Market-to-be-worth-US-4-074-6-million-by-2026-TMR.html

0 votes

Global Pharmacy Automation Systems Market – Overview

Growing incidences of injuries as well as deaths because of the mistakes in the medical prescriptions are putting a constant pressure on the overall healthcare sector. Both the healthcare service providers as well as the pharmacists are looking out for more effective and accurate technologies to prevent such recurring medical mishaps. In addition to this, the medication distribution system is turning more complex each passing day with the growing number of patients, visitors, and their respective safety needs.

Advanced technologies such as pharmacy automation systems are now coming up as the most efficient tools to tackle this serious problem. The objective of these tools is to reduce the errors in medical prescriptions and optimize patient safety. Installation of such pharmacy automation systems is thus helping healthcare service providers and pharmacists to cut down their losses and scale up efficiency and productivity.

Report Overview @ https://www.transparencymarketresearch.com/pharmacy-automation-systems.html

Global Pharmacy Automation Systems Market – Notable Developments

Some of the leading companies in the global pharmacy automation systems market include names such as Parata System Inc., Kirby Lester, McKesson Corp, and Omnicell Inc. among others. These leading players in the market are concentrating on product development and innovation to build their brand name and generate more revenue.

Some of the recent notable developments in the global pharmacy automation systems market are given below:

  • In 2016, Omnicell announced that the company has launched SureMed software by Omnicell Guided Packing. This software was developed with an objective to improve the accuracy of the pharmacists’ in filling numerous SureMed medication blister cards.
  • In 2016, BD announced a launch of a new software for Pyxis ES System. The new product will ensure safety of patient and also ensure the workflow benefits for health systems’ medication management.

Get a Glimpse of the In-Depth Analysis through our Comprehensive “Pharmacy Automation Systems Market” Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=815

Global Pharmacy Automation Systems Market – Drivers and Restraints

The growth of the pharmacy automation systems market is primarily driven by the fact that there have been initiatives to improve the reimbursement policies and stricter governmental regulation policies. With mandates in place about the dosage, prescription labeling, and packaging among others, the use of pharmacy automated systems is helping to scale up the productivity of the pharmacies.

Another important factor that has been pushing the growth of the global pharmacy automation systems market is increasing pressure on the healthcare service providers to cut down the medication errors. Moreover, there has been a substantial rise in terms of number of patients across the globe who need prescription drugs. This coupled with growing healthcare expenditure has significantly highlighted the importance of using pharmacy automation systems. Naturally, the growth of the market is moving in the right direction.

Global Pharmacy Automation Systems Market – Geographical Outlook

From a geographical point of view, the global pharmacy automation systems market is primarily divided into five main regions viz. North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Of these mentioned segments, the global pharmacy automation systems is currently dominated by the regional segment of North America. A developed healthcare infrastructure coupled with increasing pressure to cut down the medication errors is prompting higher adoption of these pharmacy automation systems. In addition to this, the government too is putting down strict regulations about the distribution prescription medicines. This too is expected to help the development of the pharmacy automation systems market in the North America region.

Pre Book “Pharmacy Automation Systems Market” Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=815&ltype=S

On the other hand, the regional segment of Asia Pacific is expected to show a promising growth in the coming years of the forecast period. The region is home to some of the fastest growing economies in the world in China and India. Both the nations are spending heavily on the development and improvement of their domestic healthcare infrastructure. This is expected to give a solid impetus to the development of pharmacy automation systems market in the Asia Pacific region.

More Trending Reports by Transparency Market Research –

Porcine Vaccines Market: prnewswire.com/news-releases/porcine-vaccines-market-to-reach-us-3208-mn-by-2025-says-tmr-679503443.html

Medical Imaging Phantoms Market: prnewswire.com/news-releases/medical-imaging-phantoms-market-to-attain-a-value-of-us180-0-million-by-2026—says-tmr-300832758.html

0 votes

The global hospital acquired diseases market is marked by the presence of renowned players in the pharmaceutical and healthcare equipment space. Rising thrust from companies on new products is building competition in the hospital acquired diseases market. Further, companies are also eyeing expansion into areas with higher potential to expand their global presence in the hospital acquired diseases market.

Some of the key players in the hospital acquired diseases testing market include Abott Laboratories, Roche, Thermo Fischer Scientific Inc., and Alere Inc. With stringent competition among the major players, it is predicted that there could be little room for new companies to emerge in the hospital acquired diseases market.

The global hospital acquired diseases testing market has been recording a phenomenal growth in the recent years. Analysts state that the market will grow at an astounding CAGR of 19.9% between 2015 and 2023. The hospital acquired diseases testing market was valued at US$ 416.7 mn in and is predicted to attain a total value of US$ 2.07 bn by the end of 2023.

Based on test, urinary tract infection is expected to fetch the highest share in the hospital acquired diseases testing market. The segment was valued at US$ 155.3 mn in 2014 and is expected to expand at a promising CAGR of 19.8%.

Planning To Lay Down Future Strategy? Request Brochure Of Hospital Acquired Disease Testing Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1759

When it comes to regions, North America is predicted to hold the highest share in the global hospital acquired diseases testing market. This region alone held 38.5% in 2014, and was followed by Asia Pacific.

Rise in Hospital Care to Shoot Up Demand in Hospital Acquired Diseases Market 

With rising awareness among people about healthcare, the need for hospital care facilities is rising. This is projected to drive demand in the global hospital acquired diseases testing market. While population in urban areas have increased access to healthcare facilities, people in rural areas are also understanding the need for hospital care for better treatment. The number of patients receiving treatment at hospitals is increasing with every year. This demands more products to prevent people from hospital acquired diseases. People are tested for hospital acquired diseases when they are under treatment in hospitals.

Further, the growing geriatric population is also considered to support demand for hospital acquired diseases testing market. Senior citizens usually have less immunity and are thus prone to easily acquire infections. This is another factor that will drive demand in the hospital acquired diseases testing market.

To Obtain All-Inclusive Information On Forecast Analysis Of Hospital Acquired Disease Testing Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1759

Lack of Healthcare Policies in Underdeveloped Nations Could Hinder Growth 

While the thrust from developed and developing nations on healthcare is emerging as a driver for the hospital acquired diseases testing market, there are some challenges too. Lack of supporting healthcare policies in underdeveloped nations is expected to hinder growth in the market.

However, several non-governmental organizations are emerging to provide help in such regions where there is no policy to support healthcare. Such trends are expected to boost demand for products in the hospital acquired diseases testing market in the future.

0 votes

The global in-vitro diagnostics market is predicted to experience brisk development in the coming years, according to a Transparency Market Research (TMR) report. The in-vitro diagnostics market comprises of a highly competitive business landscape, with a large pool of vendors across the globe. Players in the global in-vitro diagnostics market are keen on focusing on research and development of innovative products. This is a key activity adopted by vendors in order to gain a brand presence in the global in-vitro diagnostics market.

Another key strategy being adopted by vendors in the global in-vitro diagnostics tests engaging in mergers and acquisitions. This is expected to aid vendors in penetrating the global market. A good instance, is the joint agreement between Sysmex Corporation and JVCKENWOOD Corporation to establish a new enterprise Creative Nanosystems Corporation. Instances like these are expected to open new avenues in the global in-vitro diagnostics market in the coming years.

Planning To Lay Down Future Strategy? Request Brochure Of In Vitro Diagnostics Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1395

TMR analysts report that the global in-vitro diagnostics market, which was worth US$55000 mn in 2016, is likely to reach a value of S$89862.2 mn by the end of 2025. The market is forecasted to rise at a 5.6% CAGR over the forecast period of 2017 to 2025.

The segment of clinical chemistry is projected to gain significant traction in the coming years. The technology held over 25% share in the global in-vitro diagnostics market in 2016. Regionally, North America is expected to account for significant revenue in the market over the forecast period. This could be due to the well-established healthcare infrastructure in the region.

Rise in Prevalence of Chronic Ailments to Drive Growth

In 2017 it was estimated that around 23.5 million Americans were living with autoimmune diseases, the National Health Institute (NIH) said. During the forecast period, the prevalence is expected to increase. In 2018, an estimated 1.7 million new cancer cases are reported and approximately 609,640 people are likely to death from cancer, the American Cancer Society (ACS reports). Regular diagnostic testing is needed for the growing geriatric population that is prone to disease. This is one of the key drivers of market growth.  

In addition, it is estimated, in terms of accuracy, portability and cost effectiveness, that technological developments will accelerate demand for IVD devices. Improved technologies such as micro-fluid miniaturization, biochips, and nano-biotechnology should help boost the demand for PoC products. Such improvements have resulted in increased access to points of diagnosis testing and the results of the tests are expected to be fast and effective.

To Obtain All-Inclusive Information On Forecast Analysis Of In Vitro Diagnostics Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1395

Preference for Minimally Invasive Surgeries to Boost Opportunity

Demand in the global in-vitro diagnostic market for non-invasive or minimally invasive processes brings new horizons. In addition, some of the other factors that support market growth are further developments in monitoring treatment and increased accessibility of over - the-counter tests. Early-stage demand for the treatment of a disease helps the market to develop traction. The fact that clinical laboratories are not needed in the tests is another reason behind the popularity of the in vitro diagnostic market. Pregnancy testing is now done with a test kit in a safe manner. As it a safe and convenient way, this is fuelling the global in-vitro diagnostics tests market.

A key factor that may hamper the in-vitro diagnostics market is the complexity involved in reimbursement of the tests. This could deter the market growth to some extent.

More Trending Reports by Transparency Market Research –

Guidewires Market –

https://www.globenewswire.com/news-release/2019/02/25/1741681/0/en/Guidewires-Market-to-generate-revenue-of-US-2-7-billion-by-2025-TMR.html

Insulin Delivery Devices Market –

https://www.globenewswire.com/news-release/2019/02/26/1742304/0/en/Insulin-Delivery-Devices-Market-is-rising-to-a-valuation-of-US-20-9-billion-by-2025-Says-TMR.html

...